Blue Jet Healthcare Q1 FY27 Results Analysis: Revenue Slips 17%, Gross Margin Improves 478 bps (BLUEJET)

Blue Jet Healthcare Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 293.11 Cr (-17.38% YoY) and PAT growth of -14.16% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Blue Jet Healthcare reported Q1 revenue decline of 17.38% YoY due to a high base, but sequential recovery of 24.91% QoQ signals PI/API destocking reversal. Gross margin improved 478 bps YoY, and the company raised Rs.800 Cr via QIP post-quarter. However, FY27 double-digit growth guidance faces a challenging start, and freight cost inflation is pressuring other expenses.

Key Investment Insights

Key Positives

• Revenue recovered 24.91% sequentially from Q4FY26 trough, indicating PI/API destocking reversal
• Gross margin expanded 478 bps YoY to 53.22% from 48.44%, driven by favorable product mix
• EBITDA margin improved 309 bps sequentially to 33.46% from 30.37% in Q4FY26
• Company raised Rs.800 Cr via QIP post-quarter, strengthening balance sheet for capex and growth

Risk Factors

• Revenue declined 17.38% YoY, putting FY27 double-digit growth guidance at risk
• Other expenses rose to 12.90% of revenue from 9.43% YoY due to freight cost inflation
• Employee costs increased 15.43% YoY, reflecting headcount additions for new projects
• Contingent tax liability of Rs.193.39 Cr remains unresolved, with only Rs.16.5 Cr deposited under protest